Michelle J. He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michelle J. He has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alina K. Widmann
Department of Psychiatry, Weill Cornell Medicine, New York, USA
1 shared publication - Anfei Li
Wills Eye Hospital, Philadelphia, Pennsylvania, USA (C.G.d.M.); Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, USA (A.L., C.G.d.M., J.M.L.).
1 shared publication Charlize Trostinsky
Binghamton University
1 shared publication- Cristina Lao-Peregrin
Department of Psychiatry, Weill Cornell Medicine
1 shared publication Deqiang Jing
Weill Cornell Medical College
1 shared publication- Francis Lap Fung Lee
The Chinese University of Hong Kong, Hong Kong
1 shared publication
Latest Publications
- 6 September 2023
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 49 (1) , 227-245
The role of neurotrophic factors in novel, rapid psychiatric treatments
Neurotrophic factors are a family of growth factors that modulate cellular growth, survival, and differentiation. For many decades, it has been generally believed that a lack of neurotrophic support led to the decreased neuronal synaptic plasticity, death, and loss of non-neuronal supportive cells seen in neuropsychiatric disorders. Traditional psychiatric medications that lead to immediate increases in neurotransmitter levels at the synapse have been shown also to elevate synaptic neurotrophic levels over weeks, correlating with the time course of the therapeutic effects of these drugs. Recent advances in psychiatric treatments, such as ketamine and psychedelics, have shown a much faster onset of therapeutic effects (within minutes to hours). They have also been shown to lead to a rapid release of neurotrophins into the synapse. This has spurred a significant shift in understanding the role of neurotrophins and how the receptor tyrosine kinases that bind neurotrophins may work in concert with other signaling systems. In this review, this renewed understanding of synaptic receptor signaling interactions and the clinical implications of this mechanistic insight will be discussed within the larger context of the well-established roles of neurotrophic factors in psychiatric disorders and treatments.
- 6 September 2023
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 49 (1) , 227-245
The role of neurotrophic factors in novel, rapid psychiatric treatments
Neurotrophic factors are a family of growth factors that modulate cellular growth, survival, and differentiation. For many decades, it has been generally believed that a lack of neurotrophic support led to the decreased neuronal synaptic plasticity, death, and loss of non-neuronal supportive cells seen in neuropsychiatric disorders. Traditional psychiatric medications that lead to immediate increases in neurotransmitter levels at the synapse have been shown also to elevate synaptic neurotrophic levels over weeks, correlating with the time course of the therapeutic effects of these drugs. Recent advances in psychiatric treatments, such as ketamine and psychedelics, have shown a much faster onset of therapeutic effects (within minutes to hours). They have also been shown to lead to a rapid release of neurotrophins into the synapse. This has spurred a significant shift in understanding the role of neurotrophins and how the receptor tyrosine kinases that bind neurotrophins may work in concert with other signaling systems. In this review, this renewed understanding of synaptic receptor signaling interactions and the clinical implications of this mechanistic insight will be discussed within the larger context of the well-established roles of neurotrophic factors in psychiatric disorders and treatments.
- Open Access
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S219
311. Role of BDNF and mGluR5 in Modulating Perseverative, Repetitive Behaviors
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S219
Open Access311. Role of BDNF and mGluR5 in Modulating Perseverative, Repetitive Behaviors